Guoxiong Han

523 citations
5 papers · 434 indexed · 1 hit paper · h-index 3
Topics
Cancer, Hypoxia, and Metabolism (3 papers)Glycosylation and Glycoproteins Research (1 paper)Biochemical and Molecular Research (1 paper)
Partner nations
China

In The Last Decade

Guoxiong Han

5 papers receiving 430 citations

Hit Papers

PI3K/Akt signaling transduction pathway, erythropoiesis a...20182026202020232018100200300400

Peers

Guoxiong Han
Comparison fields: 5 of 87
  • Molecular Biology 229
  • Cancer Research 131
  • Oncology 53
  • Immunology 49
  • Pulmonary and Respiratory Medicine 37
Replace Yuhai Gu with:
Yuhai Gu China
Jianming Feng China
Yujie Lu China
Sha Yan China
Weiwei Yuan China
Rihua Zhang China
Xi Jiang China
Xiaoduo Dong Singapore
Yamei Hu China
Guoxiong Han relative to Yuhai Gu China Yuhai Gu's profile →
Citations per field
00.5×1.5×
Yuhai Gu · 1×
Citations per year

Countries citing papers authored by Guoxiong Han

Since Specialization
Citations

This map shows the geographic impact of Guoxiong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxiong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxiong Han more than expected).

Fields of papers citing papers by Guoxiong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxiong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxiong Han. The network helps show where Guoxiong Han may publish in the future.

Co-authorship network of co-authors of Guoxiong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxiong Han. A scholar is included among the top collaborators of Guoxiong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxiong Han. Guoxiong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 1
2 6
3 2
4
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)breakdown →
423
5
[The role of CXCR3 and its ligand I-TAC in the pathogenesis of immune thrombocytopenic purpura].
2

About Guoxiong Han

Guoxiong Han is a scholar working on Cancer Research, Biotechnology and Emergency Medicine, having authored 5 papers that have together received 434 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Cancer Research (131 citations), Aging (7 citations) and Molecular Biology (229 citations). Guoxiong Han has collaborated with scholars based in China. Frequent co-authors include Jianping Li, Wenqian Li, Yuhai Gu, Xuefeng Shi, Qiangqiang Zhao, Jianming Feng, Feng Guan, Xiang Li, Yi Wang and Ziyan Zhao. Their work appears in journals such as Aging, Molecular Medicine Reports and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026